BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Tosetti C, Nanni I. Use of proton pump inhibitors in general practice. World J Gastrointest Pharmacol Ther 2017; 8(3): 180-185 [PMID: 28828196 DOI: 10.4292/wjgpt.v8.i3.180]
URL: https://www.wjgnet.com/1007-9327/full/v8/i3/180.htm
Number Citing Articles
1
Devin Abrahami, Emily Gibson McDonald, Mireille E Schnitzer, Alan N Barkun, Samy Suissa, Laurent Azoulay. Proton pump inhibitors and risk of gastric cancer: population-based cohort studyGut 2022; 71(1): 16 doi: 10.1136/gutjnl-2021-325097
2
Ilaria Ardoino, Manuela Casula, Giulia Molari, Sara Mucherino, Valentina Orlando, Enrica Menditto, Carlotta Franchi. Prescription Appropriateness of Drugs for Peptic Ulcer and Gastro-Esophageal Reflux Disease: Baseline Assessment in the LAPTOP-PPI Cluster Randomized TrialFrontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.803809
3
F. Jeffrey Lorenz, David Goldenberg. Hypocalcemia after parathyroidectomy in patients taking proton pump inhibitorsAmerican Journal of Otolaryngology 2023; 44(2): 103761 doi: 10.1016/j.amjoto.2022.103761
4
Elizabeth M. Salvo, Nicole C. Ferko, Sarah B. Cash, Ailish Gonzalez, Peter J. Kahrilas. Umbrella review of 42 systematic reviews with meta‐analyses: the safety of proton pump inhibitorsAlimentary Pharmacology & Therapeutics 2021; 54(2): 129 doi: 10.1111/apt.16407
5
Janet A Wilson, Deborah D Stocken, Gillian C Watson, Tony Fouweather, Julian McGlashan, Kenneth MacKenzie, Paul Carding, Yakubu Karagama, Meredydd Harries, Stephen Ball, Sadie Khwaja, Declan Costello, Ruth Wood, Jan Lecouturier, James O’Hara. Lansoprazole for persistent throat symptoms in secondary care: the TOPPITS RCTHealth Technology Assessment 2021; 25(3): 1 doi: 10.3310/hta25030
6
Cheng Mei Li, Alexandra Zhernakova, Lars Engstrand, Cisca Wijmenga, Nele Brusselaers. Systematic review with meta‐analysis: the risks of proton pump inhibitors during pregnancyAlimentary Pharmacology & Therapeutics 2020; 51(4): 410 doi: 10.1111/apt.15610
7
Zakaria Bekhali, Magnus Sundbom. Low Risk for Marginal Ulcers in Duodenal Switch and Gastric Bypass in a Well-Defined Cohort of 472 PatientsObesity Surgery 2020; 30(11): 4422 doi: 10.1007/s11695-020-04822-8
8
Ibrahim O. Sawaid, Abraham O. Samson. Proton Pump Inhibitors and Cancer Risk: A Comprehensive Review of Epidemiological and Mechanistic EvidenceJournal of Clinical Medicine 2024; 13(7): 1970 doi: 10.3390/jcm13071970
9
Esmee M. Breddels, Johanna Simin, Romina Fornes, Helene Lilja Engstrand, Lars Engstrand, Robin Bruyndonckx, Nele Brusselaers. Population-based cohort study: proton pump inhibitor use during pregnancy in Sweden and the risk of maternal and neonatal adverse eventsBMC Medicine 2022; 20(1) doi: 10.1186/s12916-022-02673-x
10
Michele Russo, Kryssia Isabel Rodriguez-Castro, Marilisa Franceschi, Antonio Ferronato, Maria Piera Panozzo, Lorenzo Brozzi, Francesco Di Mario, Pellegrino Crafa, Giovanni Brandimarte, Antonio Tursi. Appropriateness of Proton Pump Inhibitor Prescription Evaluated by Using Serological MarkersInternational Journal of Molecular Sciences 2023; 24(3): 2378 doi: 10.3390/ijms24032378
11
Anouk Veldhuis, Danielle Sent, Rik J. B. Loijmans, Ameen Abu-Hanna, Vijayaprakash Suppiah. Time-dependent association between STOPP and START criteria and gastrointestinal bleeding in older patients using routinely collected primary care dataPLOS ONE 2023; 18(12): e0292161 doi: 10.1371/journal.pone.0292161
12
Su-Yeon Yu, Boram Lee, Treasure M. McGuire, Hye-Jae Lee, Samantha A. Hollingworth. Consumption of medicines used for gastric acid-related disorders in Australia and South Korea: a cross-country comparisonEuropean Journal of Clinical Pharmacology 2020; 76(4): 547 doi: 10.1007/s00228-019-02798-8
13
Mishah Azhar, Lawrence Fiedler, Patricio S. Espinosa, Charles H. Hennekens. Proton Pump Inhibitors and Risk of Dementia: A Hypothesis Generated but Not Adequately TestedAmerican Journal of Alzheimer's Disease & Other Dementias® 2021; 36 doi: 10.1177/15333175211062413
14
Ravindra B N, Dr.Parvathi K, Dr.Sruthi Sunny, Dr.Akhil Jain. Study on Drug Utilization and Evaluation of Proton Pump Inhibitors in Surgery Unit of Tertiary Care Teaching HospitalInternational Journal of Pharmaceutical Sciences Review and Research 2022; : 55 doi: 10.47583/ijpsrr.2022.v76i01.011
15
Jianke Li, Denise Trone, Jeanne Mendell, Patrick O’Donnell, Natalie Cook. A drug–drug interaction study to assess the potential effect of acid-reducing agent, lansoprazole, on quizartinib pharmacokineticsCancer Chemotherapy and Pharmacology 2019; 84(4): 799 doi: 10.1007/s00280-019-03915-1
16
Alejandro Castro‐Rodríguez, Manuel E. Machado‐Duque, Andrés Gaviria‐Mendoza, Diego A. Medina‐Morales, Tatiana Álvarez‐Vera, Jorge E. Machado‐Alba. Factors related to excessive polypharmacy (≥15 medications) in an outpatient population from ColombiaInternational Journal of Clinical Practice 2019; 73(3): e13278 doi: 10.1111/ijcp.13278
17
Abdallah Damin Abukhalil, Siham Al-Imam, Mohammad Yaghmour, Raghad Abushama, Laith Saad, Hiba Falana, Hani A Naseef. Evaluating Inappropriate Medication Prescribing Among Elderly Patients in Palestine Using the STOPP/ START CriteriaClinical Interventions in Aging 2022; : 1433 doi: 10.2147/CIA.S382221
18
Panagiota Voukelatou, Ioannis Vrettos, Georgia Emmanouilidou, Konstantinos Dodos, Georgia Skotsimara, Dimitra Kontogeorgou, Andreas Kalliakmanis. Predictors of Inappropriate Proton Pump Inhibitors Use in Elderly PatientsCurrent Gerontology and Geriatrics Research 2019; 2019: 1 doi: 10.1155/2019/7591045